| UPDATED: 20:50, Mon, Mar 1, 2021
Link copied
Macron: Expert discusses criticism against French President Sign up to receive our rundown of the day s top stories direct to your inbox
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
France, along with many other countries in the EU, has struggled to deliver vaccines to its population as President Emmanuel Macron comes under mounting pressure. It comes amid ongoing tension between European leaders and pharmaceutical company AstraZeneca. The company has failed to meet its delivery targets as Mr Macron s France has only managed to hand out 550,000 first doses of the vaccine per week so far. Reuters reported on Tuesday that AstraZeneca expects to deliver less tha
With case counts rising, Germany nervously eyes next Covid-19 ruling bna.bh - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bna.bh Daily Mail and Mail on Sunday newspapers.
Mr Mertens said on Friday Stiko would update its recommendation on the Oxford jab “very soon”, saying it was “possible” over-65s would be cleared to take it.
In an interview with German broadcaster ZDF, he defended Stiko’s initial ruling on the vaccine, and pointed to a lack of data available at the time.
He said: “We never criticised the vaccine, we just criticised the lack of data for the over-65 age group.”
But he then admitted the distinction between the vaccines efficacy and a lack of data was lost on the German public, and added: “The whole thing has somehow gone wrong.”
Germany: AstraZeneca vaccine priority groups should be abolished msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.